PhaseBio Pharmaceuticals, Inc. (PHAS)


PhaseBio Pharmaceuticals, Inc. (PHAS)

$12.27 USD

0.65 (5.59%)

Updated Jun 17 4:00pm

Add PHAS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

PHAS Daily Price Range
PHAS 52-Week Price Range

PHAS News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All PHAS News

PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio


PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.

PHAS Stock Chart More Charts


PHAS Price/Volume Stats

Current price $12.27
Prev. close $11.62
Day low $11.41
Day high $12.41
50-day MA $12.28
200-day MA $0.00
52-week high $16.65
52-week low $2.55
Volume 261,500
Avg. volume 306,763
Dividend yield N/A
Market Cap 300.59M

PHAS Social Stream


Loading social stream, please wait...

View Full PHAS Social Stream

PHAS Returns

1-mo 14.14%
3-mo 97.90%
6-mo 254.62%
1-year N/A
3-year N/A
5-year N/A
YTD 297.09%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
Page generated in 0.3959 seconds.